Literature DB >> 11733584

More on BSE/vCJD.

A J Beale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11733584      PMCID： PMC1282290          DOI： 10.1177/014107680109401201

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  7 in total

1.  Consequences of manganese replacement of copper for prion protein function and proteinase resistance.

Authors:  D R Brown; F Hafiz; L L Glasssmith; B S Wong; I M Jones; C Clive; S J Haswell
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  Unexamined assumptions in explorations of upper limit for cases of variant Creutzfeldt-Jakob disease.

Authors:  P Bacchetti
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

3.  Retrospective study of prion-protein accumulation in tonsil and appendix tissues.

Authors:  J W Ironside; D A Hilton; A Ghani; N J Johnston; L Conyers; L M McCardle; D Best
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

4.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

Review 5.  New variant Creutzfeldt-Jakob disease: the epidemic that never was.

Authors:  G A Venters
Journal:  BMJ       Date:  2001-10-13

6.  BSE and vCJD: what is the future?

Authors:  A J Beale
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

7.  Aberrant metal binding by prion protein in human prion disease.

Authors:  B S Wong; S G Chen; M Colucci; Z Xie; T Pan; T Liu; R Li; P Gambetti; M S Sy; D R Brown
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372
  7 in total
  1 in total

1.  More on BSE/vCJD.

Authors:  Gordon T Stewart
Journal:  J R Soc Med       Date:  2002-02       Impact factor: 18.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.